Home > Boards > US Listed > Medical - Drugs >

Novartis (NVS)

NVS RSS Feed
Add NVS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/29/2020 4:38:51 AM - Followers: 18 - Board type: Free - Posts Today: 0
NVS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVS News: Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US 09/16/2020 02:00:00 PM
NVS News: Report of Foreign Issuer (6-k) 09/01/2020 06:06:34 AM
NVS News: Report of Foreign Issuer (6-k) 08/20/2020 02:22:21 PM
NVS News: Report of Foreign Issuer (6-k) 06/25/2020 03:18:41 PM
PostSubject
#404   NVS/GMAB—FDA approves Kesimpta—(subcutaneous ofatumumab)—for MS: DewDiligence 08/20/20 03:09:09 PM
#403   Ofatumumab PFUFA delayed 3mo—>Sep 2020 for MS indication: DewDiligence 06/02/20 04:35:06 PM
#402   What am I missing here? Why is no fung_derf 05/19/20 09:57:59 AM
#401   NVS concedes Beovu has new safety issue: DewDiligence 04/09/20 12:22:26 PM
#400   Ok thank you Maddog 112 03/23/20 07:03:30 AM
#399   It won't have any effect at all on DewDiligence 03/22/20 10:26:35 PM
#398   How much will this affect the stock price Maddog 112 03/22/20 10:13:54 PM
#397   Yes—that was announced on Friday: #msg-154462215. DewDiligence 03/22/20 10:09:51 PM
#396   Is it true NVS to supply 160 mil Maddog 112 03/22/20 09:43:52 PM
#395   More on the same story (Beovu safety): DewDiligence 02/25/20 11:04:06 AM
#394   Acceptance of a BLA/NDA application for review doesn’t DewDiligence 02/25/20 07:17:30 AM
#393   And so this got ignored. :-( Ecomike 02/24/20 09:32:15 PM
#392   The cause is a safety update re Beovu DewDiligence 02/24/20 02:40:46 PM
#391   5.5% drop on a biotech drug firm like Ecomike 02/24/20 02:35:21 PM
#390   NVS 12/5/19 R&D Day slides: DewDiligence 12/08/19 06:53:17 PM
#389   NVS PR in conjunction with R&D Day investor webcast: DewDiligence 12/05/19 07:37:24 PM
#388   These shares are a BUY - Up and elotto777 11/26/19 12:02:02 PM
#387   NVS acquires MDCO for $85/sh cash—a 64% premium DewDiligence 11/24/19 03:47:35 PM
#386   CHMP approves NVS’ Mayzent for SPMS: DewDiligence 11/15/19 09:57:19 AM
#385   News: $NVS ROSEN, A LEADING GLOBAL LAW FIRM, whytestocks 11/09/19 08:45:26 PM
#384   FDA approves NVS’ Beovu—(a/k/a brolucizumab/RTH258) for wet AMD—3mo DewDiligence 10/08/19 10:18:25 AM
#383   Here's the cause of today's sell-off: DewDiligence 08/06/19 03:10:04 PM
#382   Any clue what too the air out this Ecomike 08/06/19 03:04:54 PM
#381   I would love to hear more about that Ecomike 07/12/19 11:54:34 AM
#380   Novartis been researching PS Phosphatidylserine targeting ? biopharm 05/28/19 07:41:28 AM
#379   Green after hours trading PennyStock Alert 05/25/19 11:46:59 AM
#378   Nice news ! PennyStock Alert 05/24/19 02:02:44 PM
#377   News: $NVS AveXis receives FDA approval for Zolgensma®, whytestocks 05/24/19 01:20:40 PM
#376   NVS Investor Day slides: DewDiligence 05/23/19 11:43:54 AM
#375   NVS PR accompanying today’s Investor Day webcast: DewDiligence 05/23/19 11:30:11 AM
#374   NVS’ QVM149* scores in phase-2 asthma trial, showing DewDiligence 05/22/19 12:30:29 PM
#373   NVS acquires Xiidra from Takeda for $3.4B up-front DewDiligence 05/08/19 07:23:44 PM
#372   AMGN and NVS are at war over Aimovig, DewDiligence 05/02/19 07:26:40 PM
#371   NVS shares declined on 4/9/19 by the implied DewDiligence 04/26/19 05:34:15 PM
#370   Higher PE sounds sweet :-) Ecomike 04/26/19 05:00:39 PM
#369   The ALC spin-off did not benefit NVS itself DewDiligence 04/26/19 04:41:54 PM
#368   DD, do you know what if anything NVS Ecomike 04/26/19 04:25:41 PM
#367   NVS completes separation of Alcon, which is now DewDiligence 04/09/19 06:41:47 PM
#366   NVS sues AMGN re Aimovig collaboration termination: DewDiligence 04/04/19 02:50:48 PM
#365   FDA approves NVS’ Mayzent* for MS—including SPMS: DewDiligence 03/26/19 07:49:22 PM
#364   If NVS Does BO AMRN, Invest83838 02/22/19 11:32:46 AM
#363   WSJ opines on the “new” Novartis: DewDiligence 11/19/18 11:06:25 AM
#362   NVS R&D Day slides (170 pages): DewDiligence 11/05/18 08:53:13 AM
#361   PFE-NVS clinical-trial collaboration in NASH: #msg-144519047. DewDiligence 10/29/18 10:14:56 AM
#360   NVS 3Q18 results: DewDiligence 10/18/18 04:05:46 PM
#359   NVS receives CRL for Ilaris in CVD: #msg-144301592. DewDiligence 10/18/18 10:34:34 AM
#358   NVS acquires ECYT for $2.1B: DewDiligence 10/18/18 10:33:30 AM
#357   AMGN, NVS launch Humira biosimilars in Europe, pursuant DewDiligence 10/16/18 11:24:18 AM
#356   ABBV settles global Humira-patent litigation with NVS: #msg-144157243. DewDiligence 10/11/18 05:24:02 PM
#355   PDUFA date for NVS’ BAF312 in SPMS—>Mar 2019 DewDiligence 10/08/18 10:01:36 AM
PostSubject
Consent Preferences